Global Electrostatic Live Cell Encapsulation Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 296.69 Million |
 Market Size (Forecast Year) |
USD 409.18 Million |
 CAGR |
% |
| Major Markets Players |
全球静电活细胞封装市场，按聚合物类型（海藻酸盐、HEMA-MMA（甲基丙烯酸羟乙酯-甲基丙烯酸甲酯）、壳聚糖、硅质封装、纤维素硫酸盐、PAN-PVC（聚丙烯腈氯乙烯）、其他）、应用（药物输送、再生医学、细胞移植、益生菌、研究）划分 - 行业趋势和预测到 2030 年。
静电活细胞封装市场分析及规模
对用于疾病治疗的新型药物输送系统的需求不断增长，推动了市场的发展，预计将成为 2023 年至 2030 年静电活细胞封装市场的潜在驱动力。支持新产品开发的公共和私人投资不断增加也促进了目标市场的增长。各种技术进步、公众对封装细胞在疾病管理中的临床作用的认识不断提高、为确定细胞封装技术临床疗效而开展的研究活动不断增加以及公众对封装细胞临床作用的认识不断提高，这些都增加了静电活细胞封装市场的规模。
Data Bridge Market Research 分析，2022 年静电活细胞封装市场规模为 2.9669 亿美元，预计到 2030 年将达到 4.0918 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 4.1%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
静电活细胞封装市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
聚合物类型（海藻酸盐、HEMA-MMA（甲基丙烯酸羟乙酯-甲基丙烯酸甲酯）、壳聚糖、硅质包覆物、硫酸纤维素、PAN-PVC（聚丙烯腈氯乙烯）、其他）、应用（药物输送、再生医学、细胞移植、益生菌、研究） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
ViaCyte, Inc. (U.S.), MIKROCAPS (Slovenia), Balchem Inc. (U.S.), Sernova Corp (Canada), Blacktrace Holdings Limited (U.K.), Merck KGaA (Germany), BÜCHI Labortechnik AG (Switzerland), PharmaCyte Biotech (U.S.), Living Cell Technologies Limited (New Zealand), Sigilon Therapeutics, Inc. (U.S.), Encapsys, LLC (U.S.), Neurotech LLC (U.S.), LycoRed Ltd. (Israel), Beta-O2 Technologies Ltd (Israel), DuPont (U.S.) and Austrianova (India) |
|
Market Opportunities |
|
Market Definition
Live cell encapsulation has long been proposed as a solution to many therapeutic problems in modern medicine. Cell encapsulation technology is used to immobilise cells within biocompatible and semipermeable membranes. Encapsulation of cells, rather than therapeutic products, is used to allow the delivery of molecules of interest for a longer time period because cells release these molecules of interest continuously. Furthermore, cells can be engineered to express the desired protein in vivo without modifying the host's genome. Cell encapsulation has a significant advantage over protein encapsulation because it allows for the sustained and controlled delivery of therapeutic molecules at a constant rate, resulting in higher physiological concentrations.
Global Electrostatic Live Cell Encapsulation Market Dynamics
Drivers
- Rising public-private investments
Growing public-private investments in product development are a key driver of the electrostatic live cell encapsulation market's expansion. Austrianova, a global company with offices in Singapore and Thailand, plans to launch a novel and proprietary technology for encapsulating living mammalian (Cell-in-a-Box) and bacterial (Bac-in-a-Box) cells in July 2021 using cellulose sulfate-based materials. As a result of this investment, Real Tech invested in a fund as a strategic partner for Austrianova's entry into the Japanese market. Such initiatives contribute to market growth during the forecast period.
Opportunities
- Increasing research programs
The growing number of research programmes aimed at proving the clinical efficacy of the cell encapsulation process is driving market growth. According to a study titled "Porous microcapsules encapsulating cells generated by microfluidic electrospray technology for diabetes treatment" published in the NGP Asia Material in May 2022, blood glucose levels and body weights improved with live cell porous microcapsules encasing cells. These characteristics indicate that porous microcapsules encasing cells are effective in the treatment of diabetes, and researchers believe that this method will be widely used in the clinic due to its superior capabilities. As a result, the efficacy of live cell encapsulation therapy in diabetes treatment is a promising approach that is expected to drive market growth.
Restraints/Challenges
- High cost of product
High product manufacturing costs and a scarcity of high-quality raw materials on the market will impede the growth of the electrostatic live cell encapsulation market from 2023 to 2030. The widespread use of alternative therapies will challenge the market's growth during the forecast period.
This electrostatic live cell encapsulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electrostatic live cell encapsulation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Sernova Corp. and Evotec SE announced a global strategic partnership to develop a best-in-class cell therapy treatment for people with insulin-dependent diabetes. The two companies will collaborate and leverage their respective technologies and scientific expertise to create an implantable iPSC-based (induced pluripotent stem cells) beta cell replacement therapy that will provide an unlimited insulin-producing cell source to patients with insulin-dependent diabetes.
- In 2022, PharmaCyte Biotech, Inc. announced that it had successfully completed a 24-month product stability study mandated by the US Food and Drug Administration (FDA) for its clinical trial product candidate, CypCaps. The significance of this timepoint is that CypCaps has now demonstrated a shelf life of at least 24 months when stored at room temperature.
Global Electrostatic Live Cell Encapsulation Market Scope
The electrostatic live cell encapsulation market is segmented on the basis of polymer type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Polymer Type
- Alginate
- HEMA-MMA (Hydroxyethyl Methacrylate-Methyl Methacrylate)
- Chitosan
- Siliceous Encapsulates
- Cellulose Sulfate
- PAN-PVC (Poly Acrylonitrile Vinyl Chloride)
- Others
Application
- Drug Delivery
- Regenerative Medicine
- Cell Transplantation
- Probiotics
- Research
Electrostatic Live Cell Encapsulation Market Regional Analysis/Insights
The electrostatic live cell encapsulation market is analyzed and market size insights and trends are provided by country, polymer type and application as referenced above.
静电活细胞封装市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美凭借其完善的医疗保健基础设施和优惠的报销政策在静电活细胞封装市场占据主导地位。
由于该地区研发活动的严格增加以及政府加强医疗保健的举措增多，预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
静电活细胞封装市场还为您提供每个国家/地区资本设备医疗保健支出增长、静电活细胞封装市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对静电活细胞封装市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和静电活细胞封装市场份额分析
静电活细胞封装市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对静电活细胞封装市场的关注有关。
静电活细胞封装市场的一些主要参与者包括：
- ViaCyte, Inc.（美国）
- MIKROCAPS（斯洛文尼亚）
- Balchem Inc.（美国）
- Sernova 公司（加拿大）
- Blacktrace Holdings Limited（英国）
- 默克集团（德国）
- BÜCHI Labortechnik AG（瑞士）
- PharmaCyte Biotech（美国）
- Living Cell Technologies Limited（新西兰）
- Sigilon Therapeutics, Inc.（美国）
- Encapsys, LLC（美国）
- Neurotech LLC（美国）
- LycoRed Ltd.（以色列）
- Beta-O2 Technologies Ltd（以色列）
- 杜邦（美国）
- Austrianova（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
